Skip to main content
. 2016 Aug 4;9:134–143. doi: 10.1016/j.redox.2016.08.001

Fig. 4.

Fig. 4

Treatment with omeprazole increases the circulating concentrations of markers of oxidative stress. (a) Xanthine oxidoreductase (XOR) activity measured by a fluorometric assay (n=8–10/group). (b) Plasma lipid peroxide concentrations measured with a fluorometric assay and expressed as malondialdehyde (MDA) concentrations (n=7/group). (c) Plasma 8-isoprostanes (8-isoPGF2α) concentrations measured with a enzyme-linked immunosorbent assay (n=7/group). Data are shown as mean±S.E.M. *P<0.05 versus normotensive animals treated with vehicle.